PeptideStack
5.2kquestions
20kanswers
220users

What is the thermal exposure on a Zhuhai to New Zealand lane in summer?

Asked 4 Feb 2025Modified 15 months agoViewed 36k times
23

Details up front: Zhuhai · New Zealand.

I want to understand what this actually establishes, as opposed to what it is being used to imply.

My concern is that I am being invited to draw a conclusion the data does not support.

What is the correct interpretation, and what is the common misreading?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
international-shipping
international-shipping

Cross-border movement of research material: transit lanes and their thermal profiles, tracked versus untracked, declaration accuracy, and what…

471 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
shareeditfollowflag
IP
askedivo_paunovic16k274 Feb 2025

5 Answers

Accepted answer first, then by votes
127

Accepted answer

Answer first: for a lyophilised solid the cold chain matters far less than people believe, and for a solution it matters far more than they act as though it does.

A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

That is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.

Solid-state stability of lyophilised peptides at ambient temperature is documented in formulation studies with residual moisture as the dominant variable.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

Lyophilised tolerates the lane. That is the answer for almost every order.

shareimprove this answerflag
MO
answered · acceptedmarta_okonkwo190k25826 Mar 2025
5The desiccant point is under-appreciated and costs nothing to act on. – cake_collapsed 6 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
51

The relevant physics is latent heat: a phase-change pack holds temperature only while it is changing phase, and once it has melted it is a warm mass.

A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.

Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

A cold pack tells you nothing about the eleven days before the last one.

Buy a logger if you actually want to know. Everything else is inference.

shareimprove this answerflag
MO
answeredmarta_okonkwo190k25815 Mar 2025
4This should be in the site help pages rather than buried in an answer. – lane_transit 4 days ago
3Aliquoting before the first freeze is the advice I wish I had read two years ago. – h_villanueva 8 months ago
add a comment
36

Worth being precise here: the domestic leg after arrival is the part most often left in a warm hallway and least often worried about.

A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

More usefully, once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

Single-use temperature loggers are standard practice in supply chains where temperature genuinely matters and are inexpensive at parcel scale.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Solutions are a different question and deserve the worry the solids get.

shareimprove this answerflag
LC
answeredlyoph_cake78k2674 Mar 2025
30

Stated carefully, this is where the anxiety in this hobby is most out of proportion to the chemistry.

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.

Reconstituted material has a genuine cold-chain requirement and it starts the moment water is added.

A liquefied pack is expected. It is not evidence of a problem.

shareimprove this answerflag
LQ
answeredlipid_panel_q36k12720 Feb 2025
24

Answering this needs the transit duration and the ambient temperature, and then the arithmetic is straightforward.

Asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

Arrhenius kinetics predict approximately a doubling of degradation rate per ten-degree rise and are the standard basis for cold-chain design.

The caveat is that "within specification" and "unchanged" are different claims. A vial can lose a few per cent of content and still be usable for its purpose while no longer matching its certificate.

The domestic leg is the part you control. Refrigerate it promptly.

shareimprove this answerflag
PH
answeredpetra_hovland35k389 May 2025
Is there a reason to prefer minus eighty here, or is minus twenty genuinely enough? – kwn_analytical 6 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.